MAPK1 and influenza: Pretreatment of HUVECs with Raf-1 inhibitor, GW 5074, phospholipase C inhibitor, U73122 and MEK/ERK inhibitor, PD98059 attenuated influenza-induced MLC phosphorylation (Fig. 6 I).